Therapeutics: Glycogen dependent kinase 3 (GSK3); dyskerin pseudouridine synthase 1 (DKC1)

Other

INDICATION: Dyskeratosis congenita

Patient sample and cell culture studies suggest GSK3 inhibitors could help treat dyskeratosis congenita, which is caused